Table 2.
Echocardiographic variables | Women | Prediabetes vs. NGT | T2DM vs. NGT | Men | Prediabetes vs. NGT | T2DM vs. NGT | Women vs. men (NGT) | Women vs. men (prediabetes) | Women vs. men (T2DM) | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NGT(n = 456) | Prediabetes (n = 274) | T2DM (n = 74) | P value§ | P value§ | NGT (n = 314) |
Prediabetes (n = 321) |
T2DM (n = 123) |
P value§ | P value§ | P values | P value | P value | |
LV end-systolic volume (LVESV) (ml) | 29.1 ± 11 | 31 ± 17 | 31.3 ± 13 | 0.1 | 0.32 | 38.9 ± 19 | 41.7 ± 23 | 42.3 ± 24 | 0.24 | 0.21 | < 0.0001 | < 0.0001 | < 0.0001 |
LV end-diastolic volume (LVEDV) (ml) | 107.5 ± 28 | 108 ± 33 | 111 ± 32 | 0.77 | 0.38 | 135.4 ± 40 | 137.5 ± 47 | 134.8 ± 41 | 0.65 | 0.72 | < 0.0001 | < 0.0001 | 0.02 |
Interventricular septal thickness (IVS) (cm) | 1.00 ± 0.2 | 1.05 ± 0.16 | 1.12 ± 0.16 | 0.07 | 0.003 | 1.13 ± 0.2 | 1.17 ± 0.15 | 1.17 ± 0.17 | 0.13 | 0.47 | < 0.0001 | < 0.0001 | 0.001 |
Posterior wall thickness (PWT) (cm) | 0.85 ± 0.14 | 0.89 ± 0.16 | 0.91 ± 0.15 | 0.02 | 0.04 | 0.93 ± 0.14 | 0.96 ± 0.14 | 0.98 ± 0.15 | 0.04 | < 0.0001 | < 0.0001 | < 0.0001 | 0.001 |
LV mass index (LVMI) (g/m2) | 95.8 ± 24 | 101.7 ± 26 | 114 ± 34 | 0.12 | 0.001 | 113.1 ± 27 | 120.7 ± 31 | 123.2 ± 33 | 0.08 | 0.01 | < 0.0001 | < 0.0001 | 0.06 |
Myocardial MEEi (ml/s g−1) | 0.41 ± 0.12 | 0.36 ± 0.10 | 0.34 ± 0.08 | < 0.0001 | < 0.0001 | 0.38 ± 0.11 | 0.35 ± 0.09 | 0.33 ± 0.1 | 0.005 | < 0.0001 | 0.001 | 0.08 | 0.39 |
Data are means ± SD, unless otherwise indicated. Comparisons between women and men were performed using unpaired Student’s t test. Comparisons between the three groups of glucose tolerance were performed using a general linear model with post hoc Fisher's least significant difference correction for pairwise comparisons. §P values refer to results after analyses with adjustment for age, smoking status, and antihypertensive therapy